Literature DB >> 26214752

Acidosis-Induced Changes in Proteome Patterns of the Prostate Cancer-Derived Tumor Cell Line AT-1.

Angelika Ihling1, Christian H Ihling2, Andrea Sinz2, Michael Gekle1.   

Abstract

Under various pathological conditions, such as inflammation, ischemia and in solid tumors, physiological parameters (local oxygen tension or extracellular pH) show distinct tissue abnormalities (hypoxia and acidosis). For tumors, the prevailing microenvironment exerts a strong influence on the phenotype with respect to proliferation, invasion, and metastasis formation and therefore influences prognosis. In this study, we investigate the impact of extracellular metabolic acidosis (pH 7.4 versus 6.6) on the proteome patterns of a prostate cancer-derived tumor cell type (AT-1) using isobaric labeling and LC-MS/MS analysis. In total, 2710 proteins were identified and quantified across four biological replicates, of which seven were significantly affected with changes >50% and used for validation. Glucose transporter 1 and farnesyl pyrophosphatase were found to be down-regulated after 48 h of acidic treatment, and metallothionein 2A was reduced after 24 h and returned to control values after 48 h. After 24 and 48 h at pH 6.6, glutathione S transferase A3 and NAD(P)H dehydrogenase 1, cellular retinoic acid-binding protein 2, and Na-bicarbonate transporter 3 levels were found to be increased. The changes in protein levels were confirmed by transcriptome and functional analyses. In addition to the experimental in-depth investigation of proteins with changes >50%, functional profiling (statistical enrichment analysis) including proteins with changes >20% revealed that acidosis upregulates GSH metabolic processes, citric acid cycle, and respiratory electron transport. Metabolism of lipids and cholesterol biosynthesis were downregulated. Our data comprise the first comprehensive report on acidosis-induced changes in proteome patterns of a tumor cell line.

Entities:  

Keywords:  LC−MS/MS; acidosis; cancer cell; gene expression; labeling

Mesh:

Substances:

Year:  2015        PMID: 26214752     DOI: 10.1021/acs.jproteome.5b00503

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  5 in total

Review 1.  Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.

Authors:  Elisabetta Iessi; Mariantonia Logozzi; Davide Mizzoni; Rossella Di Raimo; Claudiu T Supuran; Stefano Fais
Journal:  Metabolites       Date:  2017-12-23

2.  Impact of the acidic environment on gene expression and functional parameters of tumors in vitro and in vivo.

Authors:  Mandy Rauschner; Luisa Lange; Thea Hüsing; Sarah Reime; Alexander Nolze; Marcel Maschek; Oliver Thews; Anne Riemann
Journal:  J Exp Clin Cancer Res       Date:  2021-01-06

3.  NRF2 regulates the glutamine transporter Slc38a3 (SNAT3) in kidney in response to metabolic acidosis.

Authors:  Adam Lister; Soline Bourgeois; Pedro H Imenez Silva; Isabel Rubio-Aliaga; Philippe Marbet; Joanne Walsh; Luke M Shelton; Bettina Keller; Francois Verrey; Olivier Devuyst; Pieter Giesbertz; Hannelore Daniel; Christopher E Goldring; Ian M Copple; Carsten A Wagner; Alex Odermatt
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

4.  IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer.

Authors:  Nadine Bley; Annekatrin Schott; Simon Müller; Danny Misiak; Marcell Lederer; Tommy Fuchs; Chris Aßmann; Markus Glaß; Christian Ihling; Andrea Sinz; Nikolaos Pazaitis; Claudia Wickenhauser; Martina Vetter; Olga Ungurs; Hans-Georg Strauss; Christoph Thomssen; Stefan Hüttelmaier
Journal:  RNA Biol       Date:  2020-09-02       Impact factor: 4.652

5.  Epithelial-Fibroblast Crosstalk Protects against Acidosis-Induced Inflammatory and Fibrotic Alterations.

Authors:  Marie-Christin Schulz; Linda Voß; Gerald Schwerdt; Michael Gekle
Journal:  Biomedicines       Date:  2022-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.